Sumitomo Pharma Co. Ltd.

In News

Free cash flow per share of Sumitomo Pharma Co.Ltd. – MUN:DPM - TradingView

TradingView - Mar 26, 2026

Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting - PR Newswire

PR Newswire - Nov 03, 2025

Sumitomo Pharma Co., Ltd. (DNPUF) Discusses Strategic Update on Reboot 2027 Progress and Introduction of Boost 2028 Growth Strategy - Slideshow (OTCMKTS:DNPUF) 2026-03-09 - Seeking Alpha

Seeking Alpha - Mar 09, 2026

Stock List: Research Stocks from Around the World - GuruFocus

GuruFocus - Mar 30, 2026

Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived Parkinson’s treatment - MSN

MSN - Mar 25, 2026

Sumitomo Pharma Hits Day High with 6.57% Surge in Stock Price - Markets Mojo

Markets Mojo - Mar 31, 2026

Optimistic Investors Push Sumitomo Pharma Co., Ltd. (TSE:4506) Shares Up 26% But Growth Is Lacking - simplywall.st

simplywall.st - Jan 10, 2026

Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com

Bloomberg.com - Feb 19, 2026

Sumitomo Pharma’s iPS Cell Parkinson’s Therapy Heads to Key Japan Regulatory Review - TipRanks

TipRanks - Feb 13, 2026

Sumitomo Pharma to Book 48.3 Billion Yen in Non-Operating Income - marketscreener.com

marketscreener.com - Mar 25, 2026

Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy - The Globe and Mail

The Globe and Mail - Mar 06, 2026

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis - PR Newswire

PR Newswire - Jul 30, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment